3 Patents
- US123310762025Alphavirus-based Replicons for Administration of Biotherapeutics
Janssen Pharmaceuticals, Inc.
0 cites - 0 cites
- US118264162023Induce and Enhance Immune Responses Using Recombinant Replicon Systems
Janssen Pharmaceuticals, Inc.
0 cites